2-Chloro-N-cyclopropylpyrimidin-4-amine

Catalog No.: 
ACEIMR260
CAS No.: 
945895-52-3
Molecular Formula: 
C7H8ClN3
Molecular Weight: 
169.62
2-Chloro-N-cyclopropylpyrimidin-4-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$55.00In stockInquiry
1g97%$104.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Chloro-N-cyclopropylpyrimidin-4-amine
IUPAC Name2-chloro-N-cyclopropylpyrimidin-4-amine
MDL No.MFCD09756900
Molecular FormulaC7H8ClN3
Molecular Weight169.62
SMILESClC1=NC=CC(NC2CC2)=N1
InChI KeyGMKDIJOOBWRXFY-UHFFFAOYSA-N
SynonymGMKDIJOOBWRXFY-UHFFFAOYSA-N | 2-Chloro-N-cyclopropyl-pyrimidin-4-amine | 2-chloro-N-cyclopropylpyrimidin-4-amine | DTXSID60624605 | SR-01000649047 | A845009 | AKOS011628789 | AM101687 | 2-Chloro-N-cyclopropyl-4-pyrimidinamine | FT-0652713 | 2-Chloro-4-(cy
CAS No.945895-52-3
PubChem CID22309651

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACEIMR260 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACNQUT007 route compound structure diagram
    ACNQUT00718600-39-0In Stock
  4. Then
  5. ACEIMR260 route product structure diagram
    ACEIMR260945895-52-3In Stock
Inquiry

2. ACEIMR260 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIMR260 route product structure diagram
    ACEIMR260945895-52-3In Stock
Inquiry

3. ACEIMR260 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEIMR260 route product structure diagram
    ACEIMR260945895-52-3In Stock
Inquiry

Comments (0)